About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials | 7,493 Studies Recruiting

Clinical TrialsProstate Cancer

Prostate Cancer Clinical Trials

Browse 7,493 clinical trials for prostate cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1401-1420 of 7,493 trials

TerminatedPRO-MERIT (Prostate Cancer Messenger RNA Immunotherapy)Open-label, multicenter, dose titration and four-arm expansion trial to evaluate the safety, tolerability, immunogenicity, and preliminary efficacy of BNT112 cancer vaccine…NCT04382898·Tucson, Arizona and 21 others WithdrawnImpact of Anticoagulants and Antiplatelets in Patients on Transurethral Resection of the ProstateBenign prostatic hyperplasia(BPH) is a common disease in urology among old men.NCT02822963·Tainan

Related Searches

prostate carcinomatrials

Data from ClinicalTrials.govTerms

CompletedStudy to Determine Effects of Vesicare on Return to Continence Post - Radical Prostatectomy (Part II)Prostate cancer is the most common non-cutaneous malignancy in men and is the 2nd leading cause of death from cancer in men.NCT01215721·Orange, California

Active not recruitingA Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate CancerTo evaluate whether Fuzuloparib plus AA-P is superior to placebo plus AA-P as first-line treatment by assessment of radiographic progression-free survival (rPFS) in mCRPC subjects…NCT04691804·Anchorage, Alaska and 146 others

TerminatedAn Open Label Randomised Trial of RNActive® Cancer Vaccine in High Risk and Intermediate Risk Patients With Prostate CancerThe purpose of this study is to evaluate the induction of immune responses against CV9104 administered by conventional intradermal injection or with a needle-free intradermal…NCT02140138·Heidelberg, Baden-Wurttemberg and 2 others

RecruitingTwo-Fraction Ultrahypofractionated Radiotherapy With Focal Boost for Intermediate Risk, Localized Prostate CancerThe goal of this clinical trial is to assess the non-inferiority irradiating low and intermediate risk, localized prostate cancer in two fractions of radiotherapy, compared to…NCT06518226·Utrecht

CompletedCMT-07-08: The PROstate Bed Evaluation StudyThis is an observational study to collect placement and tracking data for patients who have the Calypso transponders implanted into the peri-prostatic tissue.NCT00763152·Scottsdale, Arizona and 1 other

RecruitingThe Effectiveness of Telemedicine Monitoring Prehabilitation in Prostate Cancer Patients Undergoing Radical ProstatectomyThe study titled " The effectiveness of telemedicine monitoring prehabilitation in prostate cancer patients undergoing radical prostatectomy " investigates the impact of a…NCT06981026·Olomouc

CompletedInternal Carotid Artery Blood Flow in Robot-Assisted Laparoscopic ProstatectomyThe purpose of this study is to evaluate the change of the internal carotid artery blood flow according to the steep trendelenburg position and pneumoperitoneum in patients…NCT04615494·Seoul

UnknownA Prospective Randomized Phase III Study Comparing Hormonal Therapy +/-DocetaxelThe primary objective was to evaluate the PSA (biochemical) progression-free survival (PFS) of high-risk metastasis-free PC patients, treated with LH-RH agonist for one year with…NCT00764166·Paris

CompletedStudy to Assess Safety and Efficacy of AsiDNA in Combination with Olaparib in Participants with Recurrent Solid TumorsThis is a phase 1b/2 open-label, multicenter, basket study to determine the safety, anti-tumor activity, tolerability, and pharmacokinetics /pharmacodynamics of AsiDNA in…NCT05700669·San Antonio, Texas

TerminatedA Phase 1 Study of Autologous Dendritic Cell Immunotherapy in Patients With mCRPCThe goal of this clinical trial was to evaluate the safety of Cellgram-DC-PC, an autologous dendritic cell-based cancer immunotherapy, in patients with metastatic…NCT04615845·Seoul

CompletedMetformin for Rising PSA Remote TrialClinical trials are critical to informing the care of patients with cancer. However, only 3-5% of patients with cancer enroll in clinical trials.NCT02376166·New York, New York

CompletedExercise Intervention Among Men With Prostate Cancer Initiating Androgen Deprivation TherapyThis research study is evaluating the impact and feasibility of a 12-week brisk walking and moderate strength training exercise intervention including a virtual component in men…NCT03070145·Boston, Massachusetts

UnknownMyProstateScore Equivalency With and Without DREThe purpose of the study is to quantify the concordance of MPS results between first-catch urine samples collected post-DRE and those collected without a DRE.NCT05700370·Phoenix, Arizona

CompletedPROSTACOX : Metastatic Prostate ChemotherapyClinical response to chemotherapy. Biological parameter (PSA) and RECIST evaluation.NCT00213694·Rouen

CompletedPhase 1 Trial of SYNC-T - Immunotherapy for Advanced/Metastatic Castration-Resistant Prostate CancerSV-102 is intended to overcome the complex and multifactorial nature of the mechanisms mediating tumor immune evasion, by the use of a combination of therapeutic agents that…NCT05544227·Mexico City

Active not recruitingRetrospective/Prospective Analysis of Surgical Outcomes of Robotic Prostatectomy at The JamesThis is a retrospective/prospective Analysis of surgical outcomes of robotic prostatectomy.NCT01643954·Columbus, Ohio

UnknownAutologous Immune Cell Therapy in Combination With LHRH-a in Patients With mCRPCStudy of autologous immune cell therapy in combination with the luteinizing hormone releasing hormone agonists (LHRH-a) in patients with metastatic castration-resistant prostate…NCT03085966·Shanghai Shi, Shanghai Municipality

RecruitingRepurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialThis is a phase 2a, randomized, double-blinded, placebo-controlled pilot clinical trial determining the impact of riluzole therapy on circulating brain derived neuropathic factor…NCT06580002·Orange, California

PreviousPage 71 of 375Next